NASDAQ: MEDS
Datameds Ai Inc Stock Ownership - Who owns Datameds Ai?

Insider buying vs selling

Have Datameds Ai Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Surendra K. AjjarapuDirector2026-06-22100,000$0.01
$500.00Buy
Prashant PatelChief Executive Officer2026-06-22100,000$0.01
$500.00Buy
Surendra K. AjjarapuDirector2026-03-315,000,000$0.20
$1.00MBuy
Surendra K. AjjarapuDirector2026-03-315,000,000$0.20
$1.00MBuy
Prashant PatelChief Executive Officer2026-03-315,000,000$0.20
$1.00MBuy
Prashant PatelChief Executive Officer2026-03-315,000,000$0.20
$1.00MBuy

1 of 1

MEDS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MEDS insiders and whales buy or sell their stock.

MEDS Shareholders

What type of owners hold Datameds Ai Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Brian Norton721.33%11,524,308$23.74MInsider
Prashant Patel585.51%9,354,365$19.27MInsider
Surendra K. Ajjarapu489.52%7,820,845$16.11MInsider
Nikul Panchal23.52%375,761$774.07kInsider
Srinivas Kalla18.36%293,333$604.27kInsider
Sajid Syed15.32%244,720$504.12kInsider
Rebecca M. Shanahan15.32%244,720$504.12kInsider
Donald William Anderson15.32%244,720$504.12kInsider
Michael L. Peterson12.52%200,000$412.00kInsider
Shafaat Pirani6.39%102,080$210.28kInsider

1 of 4

MEDS vs Pharmaceutical Retailer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MEDS0.00%100.00%Net Buying
HKPD0.03%2.26%
SCNX0.01%99.99%
RDGT0.00%100.00%Net Buying
POM0.00%18.34%

Datameds Ai Stock Ownership FAQ

Who owns Datameds Ai?

Datameds Ai (NASDAQ: MEDS) is owned by 0.00% institutional shareholders, 1,903.09% Datameds Ai insiders, and 0.00% retail investors. Brian Norton is the largest individual Datameds Ai shareholder, owning 11.52M shares representing 721.33% of the company. Brian Norton's Datameds Ai shares are currently valued at $25.35M.

If you're new to stock investing, here's how to buy Datameds Ai stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.